| First Sight Creatives Corporation | |
|
12302 Garden Grove Blvd Ste 6, Garden Grove, CA 92843-1802 | |
| (714) 590-2020 | |
| (714) 590-2044 |
| Full Name | First Sight Creatives Corporation |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 12302 Garden Grove Blvd Ste 6, Garden Grove, California |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174121750 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Provider Name | Melissa Zhao |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1013323047 PECOS PAC ID: 5597086777 Enrollment ID: I20150601001536 |
News Archive
Researchers at Johns Hopkins have established a high-efficiency cell-cell fusion system, providing a new model to study how fusion works. The scientists showed that fusion between two cells is not equal and mutual as some assumed, but, rather, is initiated and driven by one of the fusion partners. The discovery, they say, could lead to improved treatments for muscular dystrophy, since muscle regeneration relies on cell fusion to make muscle fibers that contain hundreds or even thousands of nuclei.
Follow-up in older adults shows a high rate of anisometropia, or differing levels of visual abnormalities between eyes, reports a study in Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Scientists identify in the journal Nature a new molecular pathway used to suppress blood vessel branching in the developing retina - a finding with potential therapeutic value for fighting diseases of the retina and a variety of cancers.
Amgen today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency adopted a positive opinion to extend the marketing authorization for Vectibix (panitumumab) to include combination with FOLFIRI (an irinotecan-based chemotherapy) as first-line treatment in adult patients with wild-type RAS metastatic colorectal cancer (mCRC).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| First Sight Creatives Corporation 12302 Garden Grove Blvd Ste 6, Garden Grove, CA 92843-1802 Ph: (714) 590-2020 | First Sight Creatives Corporation 12302 Garden Grove Blvd Ste 6, Garden Grove, CA 92843-1802 Ph: (714) 590-2020 |
News Archive
Researchers at Johns Hopkins have established a high-efficiency cell-cell fusion system, providing a new model to study how fusion works. The scientists showed that fusion between two cells is not equal and mutual as some assumed, but, rather, is initiated and driven by one of the fusion partners. The discovery, they say, could lead to improved treatments for muscular dystrophy, since muscle regeneration relies on cell fusion to make muscle fibers that contain hundreds or even thousands of nuclei.
Follow-up in older adults shows a high rate of anisometropia, or differing levels of visual abnormalities between eyes, reports a study in Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Scientists identify in the journal Nature a new molecular pathway used to suppress blood vessel branching in the developing retina - a finding with potential therapeutic value for fighting diseases of the retina and a variety of cancers.
Amgen today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency adopted a positive opinion to extend the marketing authorization for Vectibix (panitumumab) to include combination with FOLFIRI (an irinotecan-based chemotherapy) as first-line treatment in adult patients with wild-type RAS metastatic colorectal cancer (mCRC).
› Verified 8 days ago
Dr. Murray Taubman, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 12568 Valley View St, Garden Grove, CA 92845 Phone: 714-894-3353 Fax: 714-373-0670 | |
Eastgate Optometry Care Optometrist Medicare: Not Enrolled in Medicare Practice Location: 11893 Valley View St, Garden Grove, CA 92845 Phone: 714-373-2020 | |
Sally Oeung, Od Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 11822 Gilbert St, Garden Grove, CA 92841 Phone: 714-636-8850 Fax: 714-636-8856 | |
Iexam Optometry, Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 9856 Westminster Ave # 125, Garden Grove, CA 92844 Phone: 714-530-0751 | |
Dr. Ngoc-thuy Trina Nguyen, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 10872 Westminster Ave, Ste 112, Garden Grove, CA 92843 Phone: 714-636-9585 Fax: 714-636-2465 | |
Dr. Kathryn Thanh Pham, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 8942 Garden Grove Blvd, Ste 104, Garden Grove, CA 92844 Phone: 714-638-0852 | |
Dr. Vincent Lee Uy, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 10931 Chapman Ave, Garden Grove, CA 92840 Phone: 714-741-3937 Fax: 714-638-3689 |